Topic Bayer

Companies Bayer

News Bayer

• Dr. Dirk Ehle appointed Head of Bayer HealthCare's Animal Health Division
  

  Dr. Dirk Ehle has been appointed Head of the Animal Health Division of Bayer HealthCare AG effective May 1, 2012. The 42-year-old succeeds Dr. Jean-Luc Lowinski, who is leaving the company at his own request. As divisional head, Ehle will also be member of the Bayer HealthCare Executive Committee. D more

• Encouraging start to the year for Bayer

  The Bayer Group saw a successful start to 2012. “All the subgroups contributed to the encouraging increase in sales, particularly CropScience, which experienced a strong start to the season,” Management Board Chairman Dr. Marijn Dekkers explained on Thursday when the first-quarter interim report was more

• Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma

  Piramal Healthcare Limited announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG  through its newly created subsidiary - Piramal Imaging SA. The portfolio includes rights to florbetaben, which is in the fi more

Publications Bayer

• Café‐au‐lait macules and intertriginous freckling in piebaldism: Clinical overlap with neurofibromatosis type 1 and Legius syndrome

  Abstract Piebaldism is an autosomal dominant disorder characterized by congenital hypopigmented patches of skin and hair and has been found to be associated with mutations in the KIT or SLUG genes. Café‐au‐lait macules (CALM) may occasionally be seen in piebaldism. There are four reports describi more

• Characterization of chromosomal mediated cadmium resistance in Pseudomonas aeruginosa strain BC15

  Abstract Cadmium (Cd) has been used extensively in metal plating, mining, paints and plastic generation etc. In this study, Cd resistance (cadR) gene was characterized from the environmental isolate Pseudomonas aeruginosa BC15. The cadR sequences showed high homology with P. aeruginosa FLH033011 more

• Gadolinium Containing Photochromic Micelles as Potential Magnetic Resonance Imaging Traceable Drug Carriers

  Abstract Novel photochromic amphipathic molecules, KMR‐AZn (Gd‐DTPA‐AZCn), composed of hydrophilic Gd‐DTPA and hydrophobic alkylated azobenzene were prepared. In aqueous environment, KMR‐AZn indicated self‐assembly. The resulting aggregates were demonstrated to be able to include a hydrophobic dr more

Market studies Bayer

• Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future

  GBI Research’s new report, “Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future”, provides in-depth analysis of the unmet need, drivers, and barriers that impact the global urological disorders market. The report analyze more

• Global Glucose Monitoring Market Report: 2012 Edition

  The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is expected to grow even further in the near future. As a result, the worldwide market for glucose monitoring devices should also grow. There is no more

• Algeria Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Algeria is a high-risk market for multinational drugmakers because of the combination of regional uncertainty and state interference in its business environment. The country’s protectionist import policies, together with its failure to anticipate consumer demands, would have damaged total more

Websites Bayer